Exploration of the potential mechanism of the Fuzheng Xiegan decoction for treating hepatocellular carcinoma based on experimental and network pharmacological analyses

Author:

Wang Menghan,Zheng Ni,Mai Zhongchao,Zhou Borong,Yang Xinlin,Zhang Miao,Xia Wei,Ye Ying

Publisher

Elsevier BV

Subject

Complementary and alternative medicine

Reference37 articles.

1. Magnesium intake and primary liver cancer incidence and mortality in the prostate, lung, colorectal and ovarian cancer screening trial;Zhong;Int. J. Cancer,2020

2. Effectiveness and safety of adjunctive traditional Chinese medicine therapy for primary liver cancer patients: a protocol for systematic review and meta analysis;Li;Medicine (Baltimore).,2020

3. Liver cancer incidence and mortality in China: temporal trends and projections to 2030;Rongshou;Chin. J. Cancer Res.,2018

4. M. Cao, H. Wang, J.F. Shi, F.Z. Bai, W.Q. Chen, Disease burden of liver cancer in China: an updated and integrated analysis on multi-data source evidence, Zhonghua Liu Xing Bing Xue Za Zhi 41(11) (2020) 1848–1858.

5. Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation;Maria;World J. Hepatol.,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3